Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study

Elvin Kedhi, Mark W. Kennedy, Akiko Maehara, Alexandra J. Lansky, Thomas C. McAndrew, Steven P. Marso, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: We sought to investigate the relationship between thin-cap fibroatheromas (TCFAs) on major adverse cardiac events (MACEs) arising from medically treated nonculprit lesions (NCLs) in patients with acute coronary syndromes (ACS) with and without diabetes mellitus (DM). Background: MACEs occur frequently in patients with DM and ACS. The impact of plaque composition on subsequent MACEs in DM patients with ACS is unknown. Methods: In the PROSPECT (Providing Regional Observations Study Predictors of Events in the Coronary Tree) study, using 3-vessel radiofrequency intravascular ultrasound, we analyzed the incidence of NCL-MACE in 2 propensity-matched groups according to the presence of DM and TCFA. Results: Among 697 patients, 119 (17.7%) had DM. The 3-year total MACE rate (29.4% vs. 18.8%; p = 0.01) was significantly higher in patients with versus without DM, driven by a higher rate of NCL-MACE in DM (18.7% vs. 10.4%; p = 0.02). Propensity score matching generated 2 balanced groups with and without DM of 82 patients each. Among DM patients, the presence of ≥1 TCFA was associated with higher NCL-MACE at 3 years (27.8% vs. 8.9% in patients without a TCFA, hazard ratio: 3.56; 95% confidence interval: 0.98 to 12.96; p = 0.04). DM patients without a TCFA had a similar 3-year rate of NCL-MACE as patients without DM (8.9% vs. 8.9%; hazard ratio: 1.09; 95% confidence interval: 0.27 to 4.41; p = 0.90). Conclusions: ACS patients with DM and ≥1 TCFA have a high rate of NCL-MACE at 3 years. In contrast, the prognosis of ACS patients with DM but no TCFAs is favorable and similar to patients without DM.

Original languageEnglish (US)
JournalJACC: Cardiovascular Imaging
DOIs
StateAccepted/In press - Sep 28 2015

Fingerprint

Diabetes Mellitus
Acute Coronary Syndrome
Confidence Intervals
Propensity Score
Research Design

Keywords

  • Diabetes mellitus
  • Major adverse cardiac events
  • Thin-cap fibroatheroma

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study. / Kedhi, Elvin; Kennedy, Mark W.; Maehara, Akiko; Lansky, Alexandra J.; McAndrew, Thomas C.; Marso, Steven P.; De Bruyne, Bernard; Serruys, Patrick W.; Stone, Gregg W.

In: JACC: Cardiovascular Imaging, 28.09.2015.

Research output: Contribution to journalArticle

Kedhi, Elvin ; Kennedy, Mark W. ; Maehara, Akiko ; Lansky, Alexandra J. ; McAndrew, Thomas C. ; Marso, Steven P. ; De Bruyne, Bernard ; Serruys, Patrick W. ; Stone, Gregg W. / Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study. In: JACC: Cardiovascular Imaging. 2015.
@article{4ae1ef8980b146ddacace7a816b59301,
title = "Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study",
abstract = "Objectives: We sought to investigate the relationship between thin-cap fibroatheromas (TCFAs) on major adverse cardiac events (MACEs) arising from medically treated nonculprit lesions (NCLs) in patients with acute coronary syndromes (ACS) with and without diabetes mellitus (DM). Background: MACEs occur frequently in patients with DM and ACS. The impact of plaque composition on subsequent MACEs in DM patients with ACS is unknown. Methods: In the PROSPECT (Providing Regional Observations Study Predictors of Events in the Coronary Tree) study, using 3-vessel radiofrequency intravascular ultrasound, we analyzed the incidence of NCL-MACE in 2 propensity-matched groups according to the presence of DM and TCFA. Results: Among 697 patients, 119 (17.7{\%}) had DM. The 3-year total MACE rate (29.4{\%} vs. 18.8{\%}; p = 0.01) was significantly higher in patients with versus without DM, driven by a higher rate of NCL-MACE in DM (18.7{\%} vs. 10.4{\%}; p = 0.02). Propensity score matching generated 2 balanced groups with and without DM of 82 patients each. Among DM patients, the presence of ≥1 TCFA was associated with higher NCL-MACE at 3 years (27.8{\%} vs. 8.9{\%} in patients without a TCFA, hazard ratio: 3.56; 95{\%} confidence interval: 0.98 to 12.96; p = 0.04). DM patients without a TCFA had a similar 3-year rate of NCL-MACE as patients without DM (8.9{\%} vs. 8.9{\%}; hazard ratio: 1.09; 95{\%} confidence interval: 0.27 to 4.41; p = 0.90). Conclusions: ACS patients with DM and ≥1 TCFA have a high rate of NCL-MACE at 3 years. In contrast, the prognosis of ACS patients with DM but no TCFAs is favorable and similar to patients without DM.",
keywords = "Diabetes mellitus, Major adverse cardiac events, Thin-cap fibroatheroma",
author = "Elvin Kedhi and Kennedy, {Mark W.} and Akiko Maehara and Lansky, {Alexandra J.} and McAndrew, {Thomas C.} and Marso, {Steven P.} and {De Bruyne}, Bernard and Serruys, {Patrick W.} and Stone, {Gregg W.}",
year = "2015",
month = "9",
day = "28",
doi = "10.1016/j.jcmg.2015.12.023",
language = "English (US)",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus. Insights From the PROSPECT Study

AU - Kedhi, Elvin

AU - Kennedy, Mark W.

AU - Maehara, Akiko

AU - Lansky, Alexandra J.

AU - McAndrew, Thomas C.

AU - Marso, Steven P.

AU - De Bruyne, Bernard

AU - Serruys, Patrick W.

AU - Stone, Gregg W.

PY - 2015/9/28

Y1 - 2015/9/28

N2 - Objectives: We sought to investigate the relationship between thin-cap fibroatheromas (TCFAs) on major adverse cardiac events (MACEs) arising from medically treated nonculprit lesions (NCLs) in patients with acute coronary syndromes (ACS) with and without diabetes mellitus (DM). Background: MACEs occur frequently in patients with DM and ACS. The impact of plaque composition on subsequent MACEs in DM patients with ACS is unknown. Methods: In the PROSPECT (Providing Regional Observations Study Predictors of Events in the Coronary Tree) study, using 3-vessel radiofrequency intravascular ultrasound, we analyzed the incidence of NCL-MACE in 2 propensity-matched groups according to the presence of DM and TCFA. Results: Among 697 patients, 119 (17.7%) had DM. The 3-year total MACE rate (29.4% vs. 18.8%; p = 0.01) was significantly higher in patients with versus without DM, driven by a higher rate of NCL-MACE in DM (18.7% vs. 10.4%; p = 0.02). Propensity score matching generated 2 balanced groups with and without DM of 82 patients each. Among DM patients, the presence of ≥1 TCFA was associated with higher NCL-MACE at 3 years (27.8% vs. 8.9% in patients without a TCFA, hazard ratio: 3.56; 95% confidence interval: 0.98 to 12.96; p = 0.04). DM patients without a TCFA had a similar 3-year rate of NCL-MACE as patients without DM (8.9% vs. 8.9%; hazard ratio: 1.09; 95% confidence interval: 0.27 to 4.41; p = 0.90). Conclusions: ACS patients with DM and ≥1 TCFA have a high rate of NCL-MACE at 3 years. In contrast, the prognosis of ACS patients with DM but no TCFAs is favorable and similar to patients without DM.

AB - Objectives: We sought to investigate the relationship between thin-cap fibroatheromas (TCFAs) on major adverse cardiac events (MACEs) arising from medically treated nonculprit lesions (NCLs) in patients with acute coronary syndromes (ACS) with and without diabetes mellitus (DM). Background: MACEs occur frequently in patients with DM and ACS. The impact of plaque composition on subsequent MACEs in DM patients with ACS is unknown. Methods: In the PROSPECT (Providing Regional Observations Study Predictors of Events in the Coronary Tree) study, using 3-vessel radiofrequency intravascular ultrasound, we analyzed the incidence of NCL-MACE in 2 propensity-matched groups according to the presence of DM and TCFA. Results: Among 697 patients, 119 (17.7%) had DM. The 3-year total MACE rate (29.4% vs. 18.8%; p = 0.01) was significantly higher in patients with versus without DM, driven by a higher rate of NCL-MACE in DM (18.7% vs. 10.4%; p = 0.02). Propensity score matching generated 2 balanced groups with and without DM of 82 patients each. Among DM patients, the presence of ≥1 TCFA was associated with higher NCL-MACE at 3 years (27.8% vs. 8.9% in patients without a TCFA, hazard ratio: 3.56; 95% confidence interval: 0.98 to 12.96; p = 0.04). DM patients without a TCFA had a similar 3-year rate of NCL-MACE as patients without DM (8.9% vs. 8.9%; hazard ratio: 1.09; 95% confidence interval: 0.27 to 4.41; p = 0.90). Conclusions: ACS patients with DM and ≥1 TCFA have a high rate of NCL-MACE at 3 years. In contrast, the prognosis of ACS patients with DM but no TCFAs is favorable and similar to patients without DM.

KW - Diabetes mellitus

KW - Major adverse cardiac events

KW - Thin-cap fibroatheroma

UR - http://www.scopus.com/inward/record.url?scp=84978513179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978513179&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2015.12.023

DO - 10.1016/j.jcmg.2015.12.023

M3 - Article

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

ER -